Thoughts on COVID-19 and autoimmune diseases
10.1136/lupus-2020-000396
April 3, 2020
Most Read Articles
Scoring systemic lupus erythematosus (SLE) disease activity with simple, rapid outcome measures
10.1136/lupus-2019-000365
December 30, 2019
Atherosclerosis in SLE: a potential role for serum parathormone levels
10.1136/lupus-2020-000393
September 10, 2020
Generating evidence to inform health technology assessment of treatments for SLE: a systematic review of decision-analytic model-based economic evaluations
10.1136/lupus-2019-000350
July 28, 2020
Multicentre retrospective cohort study assessing the incidence of serious infections in patients with lupus nephritis, compared with non-renal systemic lupus erythematosus
10.1136/lupus-2020-000390
September 22, 2020
Prediction of prognosis and renal outcome in lupus nephritis
10.1136/lupus-2020-000389
February 18, 2020
Impact of COVID-19 pandemic on SLE: beyond the risk of infection
10.1136/lupus-2020-000408
May 5, 2020
Could severe COVID-19 be considered a complementopathy?
10.1136/lupus-2020-000415
May 19, 2020
Programme
10.1136/lupus-2020-la.programme
September 1, 2020
Disease duration, age at diagnosis and organ damage are important factors for cardiovascular disease in SLE
10.1136/lupus-2020-000398
June 24, 2020